News
In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.
Prostate CA bone lesions, locations can predict survival benefits of add-on radiation
By Marilynn Larkin NEW YORK (Reuters Health) - In newly diagnosed prostate cancer patients, bone metastatic burden and metastasis location can predict the survival benefits of add-on radiation,
PICaSSO tool promising for predicting histologic remission in ulcerative colitis
By Marilynn Larkin NEW YORK (Reuters Health) - The recently developed Paddington International Virtual ChromoendoScopy ScOre (PICaSSO) accurately identified both endoscopic and histologic remission in
Phenobarbital for NOWS tied to shorter morphine duration, briefer hospital stay
By Lisa Rapaport (Reuters Health) - Infants with neonatal opioid withdrawal syndrome (NOWS) may have shorter hospital stays and spend less time on morphine when they receive phenobarbital as secondary
CTE risk not influenced by football, hockey positions played
By Lisa Rapaport (Reuters Health) - Athletes who play contact sports like football and hockey may have a similar risk of chronic traumatic encephalopathy (CTE) regardless of what position they play, a
App-based exercise program decreases knee osteoarthritis pain
By Lisa Rapaport (Reuters Health) - An app-based exercise program may be more effective for easing pain from knee osteoarthritis than usual care alone, a small study suggests. Researchers randomized
Option B+ antiviral regimen helps mothers achieve HIV suppression
By Lisa Rapaport (Reuters Health) - Antiretroviral therapy (ART) initiated during pregnancy and continued postpartum to help prevent maternal-child transmission of HIV may also help mothers sustain
Disparities in rhythm control treatment for atrial fibrillation
By Linda Carroll (Reuters Health) - During a three-year period ending in 2019, use of rhythm control in atrial fibrillation patients increased, but minorities and lower-income patients were less
Brazil prosecutors seek to stop purchase of Indian vaccine
By Reuters Staff BRASILIA (Reuters) - Brazilian prosecutors are seeking the immediate suspension of purchases of India's COVID-19 vaccine COVAXIN, according to a document seen by Reuters on Friday,
Poles go underground for COVID treatment in UNESCO-listed salt mine
By Reuters Staff WIELICZKA, Poland (Reuters) - A UNESCO World Heritage site in Poland is being used to help people recover from COVID-19, with patients going deep underground in the Wieliczka salt
U.S. urges vaccine-sceptical Tanzania to review evidence on the COVID-19 shots
By Reuters Staff NAIROBI (Reuters) - The Unites States urged vaccine-sceptical Tanzania on Friday to review evidence on the drugs, saying they work and are one of the tools to fight off the COVID-19
UPDATE 1-'Things are tenuous,' U.S. CDC says as downward trend in COVID-19 cases stalls
(Adds quotes from officials) By Reuters Staff WASHINGTON (Reuters) - The head of the U.S. Centers for Disease Control and Prevention said on Friday that a recent decline in COVID-19 cases may be
U.S. CDC says trend of decline in COVID-19 cases may be stalling
By Reuters Staff WASHINGTON (Reuters) - The head of the U.S. Centers for Disease Control and Prevention said on Friday that a recent decline in COVID-19 cases may be stalling, a development she
Timing, ethics factor into COVID-19-vaccine trial enrollment of minors
By Carolyn Crist NEW YORK (Reuters Health) - As manufacturers of COVID-19 vaccines consider when and how to enroll minors into clinical trials, several factors such as timing and ethics should be
Water jelly could help with aspiration pneumonia in older patients
By Carolyn Crist NEW YORK (Reuters Health) - Older patients who have moderate or severe dysphagia, or difficulty with swallowing, could benefit from using water jelly after meals to prevent aspiration
Rhabdomyolysis a presenting sign of COVID-19 in an adolescent
By Megan Brooks NEW YORK (Reuters Health) - COVID-19 infection may present as severe rhabdomyolysis in children, clinicians in Chicago report. In the journal Pediatrics, they describe a 16-year-old
New tool to aid accurate Lupus diagnosis
By Megan Brooks NEW YORK (Reuters Health) - Clinicians in Greece have developed and validated a simple and accurate tool to aid diagnosis of systemic lupus erythematosus (SLE) based on standard
Bedaquiline and delamanid safe together against rifampicin-resistant TB
By David Douglas NEW YORK (Reuters Health) - New research suggests concerns over the concurrent use of bedaquiline and delamanid in patients with drug-resistant tuberculosis were unwarranted. "Prior
Risk of human spread of H5N8 bird flu deemed low - WHO
By Stephanie Nebehay GENEVA (Reuters) - The risk of human-to-human spread of the H5N8 strain of bird flu appears low after it was identified for the first time worldwide in farm workers in Russia, the
UK to prioritise next stage of COVID-19 vaccines by age, not job
By Alistair Smout LONDON (Reuters) - Police and teachers will not jump to the head of the queue in the second phase of Britain's COVID-19 vaccination rollout, with people instead prioritised by age,
Spain to give just one vaccine dose to under 55-year olds who had COVID-19
By Reuters Staff MADRID (Reuters) - Spain will give a single vaccine dose to under 55-year-olds who have already been infected with COVID-19, the Health Ministry announced on Friday in the latest
FDA advisory panel to review Johnson & Johnson COVID-19 vaccine with thumbs up expected
By Manas Mishra and Michael Erman (Reuters) - A panel of expert advisers to the U.S. Food and Drug Administration began a meeting to discuss Johnson & Johnson's one-dose COVID-19 vaccine on Friday,
FOCUS-AstraZeneca, Sputnik vaccines face hurdles if COVID shots become annual affair
By John Miller and Ludwig Burger ZURICH (Reuters) - Vaccines from AstraZeneca, Russia's Gamaleya Institute and Johnson & Johnson fight the coronavirus with another virus, leaving scientists concerned
Pfizer COVID-19 vaccine reduces infection risk after one dose -UK study
By Kate Kelland LONDON (Reuters) - A single dose of Pfizer and BioNtech's COVID-19 vaccine cuts the number of asymptomatic infections and could significantly reduce the risk of transmission of the
AstraZeneca-Amgen drug could widen treatment options for severe asthma
By Pushkala Aripaka Feb 26 (Reuters) - AstraZeneca and Amgen's experimental drug reduced asthma attacks in patients with severe and uncontrolled forms of the respiratory condition in a large study,
MRI likely safe for patients with abandoned cardiac device leads
By Marilynn Larkin NEW YORK (Reuters Health) - Patients with abandoned cardiac implantable electronic device (CIED) leads are at low risk from magnetic resonance imaging (MRI) and may safely undergo
No survival benefit to primary resection before chemo in metastatic colorectal cancer
By Marilynn Larkin NEW YORK (Reuters Health) - Contrary to previous reports, primary tumor resection prior to chemotherapy did not confer a survival benefit in colorectal cancer patients in a
New York officials, others downplay concern over new coronavirus variant
By Peter Szekely NEW YORK (Reuters) - Mayor Bill de Blasio's chief medical adviser on Thursday downplayed the results of two studies that may suggest a new coronavirus variant found in New York City
Cognitive behavioral program may prevent insomnia in at-risk adolescents
By Lisa Rapaport (Reuters Health) - Adolescents with a family history of insomnia and subthreshold insomnia symptoms may be able to avoid developing insomnia by undergoing cognitive behavioral therapy
Gamma-linolenic acid supplement may help reduce blood pressure in postmenopausal women
By Lisa Rapaport (Reuters Health) - Postmenopausal women who take gamma-linolenic acid supplements in addition to vitamin E may experience larger reductions in blood pressure than those taking vitamin
Transplant patient dies after receiving SARS-CoV-2 infected lungs
By Linda Carroll (Reuters Health) - A lung transplant patient died after receiving SARS-CoV-2-infected lungs from a donor with a negative nasopharyngeal test, according to a U.S. case report. The
Weary of new COVID variants, EU leaders push to step up vaccination
By Sabine Siebold and Jan Strupczewski BRUSSELS (Reuters) - German Chancellor Angela Merkel said the European Union must prepare to vaccinate for new COVID-19 variants over the coming years after EU
Delayed umbilical cord clamping has some benefits in term and preterm babies
By Megan Brooks NEW YORK (Reuters Health) - Delayed umbilical cord clamping appears to be associated with some benefits for term and preterm born infants, according to literature reviews by the
Ireland sees strong early evidence that vaccines are working
By Padraic Halpin DUBLIN (Reuters) - Ireland is beginning to see strong early evidence that its COVID-19 vaccine rollout is protecting healthcare workers and care home residents from catching the
U.S. school closings have limited impact on COVID-19 incidence, mortality
By Lisa Rapaport (Reuters Health) - School closings appear to have a smaller impact on COVID-19 incidence and mortality than behavioral changes such as bans on large gatherings and restaurant closings
FACTBOX-A patchwork: Europe and COVID-19 vaccination passports
By Reuters Staff (Reuters) - European Union leaders moved closer on Thursday to an agreement on certificates showing that citizens have been vaccinated against COVID-19, a move that could revive
EU drug regulator outlines plan to fast track variant-modified COVID vaccines
By Reuters Staff (Reuters) - Europe's medicines regulator said on Thursday it has issued new guidance for drug makers that modify their COVID-19 vaccines to protect against variants of the virus to
Ad campaign to combat vaccine hesitancy in U.S. with celebrity help
By Sheila Dang (Reuters) - The Ad Council launched a campaign on Thursday designed to combat hesitancy about the safety of the coronavirus vaccine, blanketing messages across U.S. TV, radio, websites
EU should review approval of plastics with toxic softener DEHP - top court adviser
By Kate Abnett BRUSSELS (Reuters) - The European Commission should review a decision to let companies use recycled plastics containing DEHP, a toxic additive, since it failed to properly consider
Post-op complications, not surgical approach, independent predictor of survival after esophagectomy
By David Douglas NEW YORK (Reuters Health) - In patients with esophageal cancer, post-op complications, but not surgical approach, is an independent predictor of survival, according to European
Anticholinergic plus alpha-blocker of 'uncertain' benefit in men with urinary problems
By Reuters Staff NEW YORK (Reuters Health) - For men with lower-urinary-tract symptoms (LUTS) due to benign prostatic obstruction, combining an anticholinergic with an alpha-blocker has "little or
Regeneron to stop giving placebo in COVID-19 drug trial after 'clear efficacy'
By Reuters Staff (Reuters) - Regeneron Pharmaceuticals said on Thursday that an independent panel found the company's COVID-19 antibody cocktail to have "clear clinical efficacy" in reducing the rates
GSK narrows focus on elderly in trial to treat pneumonia from COVID-19
By Ludwig Burger FRANKFURT (Reuters) - GlaxoSmithKline will extend a trial testing an experimental rheumatoid arthritis drug on patients suffering from pneumonia related to COVID-19 to focus on the
Debilitating 'long-COVID' may have severe health, social impacts - WHO
By Kate Kelland LONDON (Reuters) - Thousands of COVID-19 patients continue to suffer serious, debilitating and lingering symptoms many months after their initial bout of infection, with major social,
EU countries report offers for 900 million COVID vaccines by 'alleged intermediaries' - anti-fraud body
By Gabriela Baczynska BRUSSELS (Reuters) - Several European Union countries have reported offers from "alleged intermediaries" for 900 million doses of COVID-19 vaccines for some 12.7 billion euros,
Pfizer-BioNTech testing booster of their COVID-19 vaccine in new trial
By Michael Erman (Reuters) - Pfizer Inc and BioNTech SE said on Thursday they are testing a third dose of their COVID-19 vaccine to better understand the immune response against new variants of the
New coronavirus variant identified in New York-researchers
By Deena Beasley (Reuters) - A new coronavirus variant that shares some similarities with a more transmissible and intractable variant discovered in South Africa is on the rise in New York City,
UPDATE 1-SOFA score not helpful for ventilator triage in patients with COVID-19 pneumonia
(Updates Feb 24 story with researcher comments.) By Reuters Staff NEW YORK (Reuters Health) - The Sequential Organ Failure Assessment (SOFA) score has "inadequate" discriminant accuracy for ventilator
In transgender youth, obesity impacts effects of sex steroids on HDL-C
By Marilynn Larkin NEW YORK (Reuters Health) - In transgender and gender-diverse young people receiving sex steroids, obesity exacerbates the decrease in high-density lipoprotein cholesterol (HDL-C)
Chemo-induced neuropathy linked with low hemoglobin, BMI, age
By Marilynn Larkin NEW YORK (Reuters Health) - Older patients with low hemoglobin and higher body mass index - particularly women - were more likely to experience chemotherapy-induced peripheral
Hypothermic machine perfusion prevents complications in donated-after-cardiac-death liver allografts
By Gene Emery (Reuters Health) - When preparing livers for transplant, hypothermic oxygenated machine perfusion (HMP) slashes the odds of nonanastomotic biliary stricture (NAS) by two thirds, cuts the
Vaginal pessaries effective for many women with pelvic organ prolapse
By Linda Carroll (Reuters Health) - For many women, especially seniors experiencing pelvic organ prolapse, vaginal pessaries may be an effective long-term treatment, a new study suggests. An analysis
Moderna developing booster shot for new coronavirus variants, increases vaccine production target
By Julie Steenhuysen and Carl O'Donnell (Reuters) - Moderna Inc said on Wednesday it is working with U.S. government scientists to study an experimental booster shot that targets a concerning new
In boost for COVID-19 battle, Pfizer vaccine found 94% effective in real world
By Maayan Lubell and Ari Rabinovitch JERUSALEM (Reuters) - The first big real-world study of the Pfizer/BioNTech vaccine to be independently reviewed shows the shot is highly effective at preventing
CAR-T-cell multiple myeloma treatment effective in early trial
By Reuters Staff NEW YORK (Reuters Health) - A chimeric antigen receptor (CAR) T-cell therapy called idecabtagene vicleucel produces a complete response in at least a third of patients with relapsed
Central muscarinic cholinergic activation promising in schizophrenia
By Reuters Staff NEW YORK (Reuters Health) - Combination therapy with xanomeline, a muscarinic-receptor agonist, and trospium, which limits xanomeline's cholinergic effects peripherally, appears to be
Modern treatment tied to low disease activity in pregnant rheumatoid arthritis patients
By Lisa Rapaport (Reuters Health) - Many pregnant women with rheumatoid arthritis may achieve low disease activity in the third trimester with a modern treatment regimen that includes anti-tumor
UPDATE 1-White House to roll out J&J vaccine doses next week, pending authorization
(Adds details from briefing) By Reuters Staff (Reuters) - The United States expects to roll out three to four million doses of Johnson & Johnson's COVID-19 vaccine next week, pending authorization
White House to roll out J&J vaccine doses next week, pending authorization
By Reuters Staff (Reuters) - The United States expects to roll out three to four million doses of Johnson & Johnson's COVID-19 vaccine next week, pending authorization from the Food and Drug
Hospitalisation risk 64% higher with UK coronavirus variant -Danish study
By Reuters Staff COPENHAGEN (Reuters) - A Danish study has found that people infected with a more contagious coronavirus variant first identified in Britain have a higher risk of being hospitalised,
Germany approves COVID home tests to ease way out of lockdown
By Reuters Staff BERLIN (Reuters) - Germany approved three COVID-19 tests for home use as part Health Minister Jens Spahn's strategy to help Europe's biggest economy emerge from a lockdown that has
S.Korea's fertility rate falls to lowest in the world
By Reuters Staff SEOUL (Reuters) - South Korea's fertility rate fell to the lowest in the world last year, data showed on Wednesday, as uncertainty over the coronavirus discouraged couples from
EU mulls vaccination passports to resurrect tourism after COVID-19
By Jan Strupczewski BRUSSELS (Reuters) - European Union leaders will agree on Thursday to work on certificates of vaccination for EU citizens who have had an anti-COVID shot, with southern EU
UPDATE 1-Johnson & Johnson's one-shot COVID-19 vaccine effective, safe- FDA staff
(Adds side effects details, new efficacy numbers for South Africa) By Reuters Staff (Reuters) - Johnson & Johnson's one-shot COVID-19 vaccine appeared safe and effective in trials, U.S. Food and Drug
Pet cats highly susceptible to SARS-CoV-2
By Reuters Staff NEW YORK (Reuters Health) - Cats are highly susceptible to SARS-CoV-2, but transmissibility is reduced as the virus spreads through cats, according to new research from China. Studies
MRI-based test promising for mass prostate-cancer screening
By David Douglas NEW YORK (Reuters Health) - Short, non-contrast magnetic resonance imaging (MRI) may be useful for a community-centered screening test for prostate cancer, according to researchers in
SOFA score not helpful for ventilator triage in patients with COVID-19 pneumonia
By Reuters Staff NEW YORK (Reuters Health) - The Sequential Organ Failure Assessment (SOFA) score has "inadequate" discriminant accuracy for ventilator triage of patients with COVID-19, clinicians
Sweden to ease COVID rules for vaccinated care home residents
By Reuters Staff STOCKHOLM (Reuters) - Sweden will ease restrictions on elderly residents of care homes who have been vaccinated against COVID-19, the country's top epidemiologist said on Wednesday,
REFILE-Empathetic phone calls from laypersons reduce loneliness, depression in homebound adults
(Clarifies in paragraph 12 that control group deterioration was not statistically significant) By Linda Carroll (Reuters Health) - A layperson-delivered empathy-oriented phone call program may reduce
First COVID-19 vaccine doses dispatched by COVAX arrive in Ghana
By Christian Akorlie ACCRA (Reuters) - The World Health Organization's global vaccine-sharing scheme COVAX delivered its first COVID-19 shots on Wednesday, as the race to get doses to the world's
Exhausted by COVID-19 fight, Portuguese nurses want pay not applause
By Catarina Demony and Pedro Nunes LISBON (Reuters) - At midnight nurse Ines Lopes and her colleagues are about to start the night shift taking care of patients in a COVID-19 intensive care unit in
China's bid to stop Wuhan COVID-19 spread cut deaths from other causes - study
By David Stanway SHANGHAI (Reuters) - The number of deaths in China - excluding the coronavirus epicentre of Wuhan - fell slightly during the first three months of 2020, suggesting efforts to control
Johnson & Johnson's one-shot COVID-19 vaccine effective, safe- FDA staff
By Reuters Staff (Reuters) - Johnson & Johnson's one-shot COVID-19 vaccine appeared safe and effective in trials, U.S. Food and Drug Administration (FDA) staff said in documents published on Wednesday
Dapagliflozin could rapidly curb worsening heart failure, death
By Marilynn Larkin NEW YORK (Reuters Health) - In heart failure patients with reduced ejection fraction, dapagliflozin was associated with a rapid reduction in the risk of cardiovascular death or
Photoselective vaporization safely alleviates refractory LUTS in prostate cancer patients
By Matthew Phelan NEW YORK (Reuters Health) - Photoselective vaporization of the prostate can provide relief from refractory lower-urinary-tract symptoms (LUTS) resulting from benign prostatic
Continuous glucose monitoring curbs hyperglycemia, hypoglycemia in preemies
By Marilynn Larkin NEW YORK (Reuters Health) - In preterm infants, continuous glucose monitoring (CGM) reduced prolonged or severe hyperglycemia and hypoglycemia in an international randomized
Pregnant women infected by COVID-19 at higher rate
By Reuters Staff (Reuters) - Pregnant women become infected with the new coronavirus at higher rates than other adults, according to new data from Washington state. Between March and June there, for
Thrombectomy an option for primary distal posterior cerebral artery occlusion stroke
By Reuters Staff NEW YORK (Reuters Health) - Mechanical thrombectomy is a "reasonable, safe and technically feasible" option for isolated posterior circulation distal, medium vessel occlusion (DMVO)
Empathetic phone calls from laypersons reduce loneliness, depression in homebound adults
By Linda Carroll (Reuters Health) - A layperson-delivered empathy-oriented phone call program may reduce loneliness as well as depression and anxiety in homebound adults, a new study suggests. Based
High-dose baclofen curbs agitation in ventilation patients with unhealthy alcohol use
By Lisa Rapaport (Reuters Health) - Adults receiving mechanical ventilation who meet the criteria for unhealthy alcohol use have fewer agitation-related events when they're given high-dose baclofen, a
UPDATE 1-COVID-19 vaccine makers tell Congress U.S. supply will surge soon
(Adds new details from hearing, CVS, background) By Michael Erman and Manojna Maddipatla NEW YORK (Reuters) - COVID-19 vaccine makers told Congress on Tuesday that U.S. supplies should surge in the
French COVID-19 intensive care patients at a 12-week high
By Reuters Staff PARIS (Reuters) - France's number of patients treated in intensive care units for COVID-19 has gone up again on Tuesday, reaching a 12-week peak of 3,435 as regional officials urge
EU to keep COVID-19 curbs on non-essential travel amid chaotic border measures
By Gabriela Baczynska and Sabine Siebold BRUSSELS/BERLIN (Reuters) - European Union government leaders will agree on Thursday to maintain curbs on non-essential travel within the EU despite the bloc's
COVID-19 vaccine makers tell Congress U.S. supply will surge soon
By Michael Erman and Manojna Maddipatla NEW YORK (Reuters) - COVID-19 vaccine makers told Congress on Tuesday that U.S. supplies should surge in the coming weeks due to manufacturing expansions and
FDA to allow Pfizer-BioNTech vaccine to be stored at higher temps - NYT
By Reuters Staff (Reuters) - The U.S. Food & Drug Administration plans to approve Pfizer Inc and BioNTech SE's request to store their COVID-19 vaccine at standard freezer temperatures instead of in
EXCLUSIVE-AstraZeneca to miss second-quarter EU vaccine supply target by half - EU official
By Francesco Guarascio BRUSSELS (Reuters) - AstraZeneca expects to deliver less than half the COVID-19 vaccines it was contracted to supply the European Union in the second quarter, an EU official
Argentine President Fernandez on defensive over vaccine scandal, warns of more firings
By Raul Cortes MEXICO CITY (Reuters) - Argentine President Alberto Fernández was on the defensive on Tuesday over a "VIP" vaccine scandal that has roiled the South American country, and said more
Greek doctors protest 'suffocating' conditions at COVID-19 clinics
By Reuters Staff ATHENS (Reuters) - Greek hospital doctors went on a day-long strike on Tuesday and dozens marched in Athens to protest "suffocating" conditions at hospitals on the frontline of the
Dialysis patients face much higher risks of COVID-19, study confims
By Scott Baltic NEW YORK (Reuters Health) - Patients undergoing long-term dialysis are increased risk of being diagnosed with COVID-19 and have a higher case fatality rate, a new study from Canada
Ivabradine helpful in postural orthostatic tachycardia syndrome
By David Douglas NEW YORK (Reuters Health) - Ivabradine treatment significantly reduces heart rate and improves quality of life in patients with postural orthostatic tachycardia syndrome (POTS), a
More disappointing results for vitamin C, thiamine and hydrocortisone in sepsis
By Megan Brooks NEW YORK (Reuters Health) - Among critically ill patients with sepsis, treatment with hydrocortisone, vitamin C (ascorbic acid) and thiamine (HAT) did not improve outcome in the
EU drug watchdog to weigh in on extended use for remdesivir by summer
By Reuters Staff (Reuters) - Europe's drugs regulator said on Tuesday it was expecting to give an opinion before the summer on whether Gilead Sciences' remdesivir can be used to treat COVID-19
French researchers to trial more accurate fast COVID-19 test
By Reuters Staff VILLENEUVE-D'ASCQ, France (Reuters) - French researchers are using tiny antibody particles extracted from the family of animals that includes camels and llamas to produce a test they
Fauci says U.S. political divisions contributed to 500,000 dead from COVID-19
By Julie Steenhuysen CHICAGO (Reuters) - Dr. Anthony Fauci, the nation's top infectious disease expert, said political divisiveness contributed significantly to the "stunning" U.S. COVID-19 death toll
Philippines offers nurses in exchange for vaccines from Britain, Germany
By Neil Jerome Morales MANILA (Reuters) - The Philippines will let thousands of its healthcare workers, mostly nurses, take up jobs in Britain and Germany if the two countries agree to donate
UPDATE 2-Trials of retooled vaccines for variants could take months -U.S. FDA
(Adds AstraZeneca comment in paragraphs 8-9) By Reuters Staff (Reuters) - Drugmakers should test any COVID-19 vaccines that have been retooled to combat new variants of the coronavirus in clinical
ctDNA levels promising for tracking melanoma treatment progress, predicting outcomes
By Marilynn Larkin NEW YORK (Reuters Health) - Circulating tumor DNA (ctDNA) levels can be used to track treatment progress and predict outcomes in patients with BRAF V600 mutation-positive
Amoxicillin-clavulanate safe, effective for uncomplicated diverticulitis
By Lisa Rapaport (Reuters Health) - Patients with uncomplicated diverticulitis who are treated in the outpatient setting with amoxicillin-clavulanate may avoid the infection risk associated with
Blood pressure risk threshold is lower in women
By Marilynn Larkin NEW YORK (Reuters Health) - Women had a lower blood pressure risk threshold than men for heart attack, stroke and heart failure in a large observational study. "When we look(ed) at
EXCLUSIVE-From gum to gummies, Beau Wrigley takes pot producer Parallel public
By Shariq Khan (Reuters) - Billionaire William "Beau" Wrigley Jr is taking cannabis producer Parallel public, in a merger due to complete this summer with Canadian-listed Ceres Acquisition Corp that
UPDATE 1-Trials of retooled vaccines for variants could take months -U.S. FDA
(Adds details, quotes from FDA news conference) By Reuters Staff (Reuters) - Drugmakers should test any COVID-19 vaccines that have been retooled to combat new variants of the coronavirus in clinical
